The Current State of Niacin in Cardiovascular Disease Prevention A Systematic Review and Meta-Regression
ConclusionsThe consensus perspective derived from available clinical data supports that niacin reduces CVD events and, further, that this may occur through a mechanism not reflected by changes in high-density lipoprotein cholesterol concentration.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholesterol | Clinical Trials | Coronary Heart Disease | Heart | Heart Disease | Metabolic Syndrome | Niacin | Niaspan | Simvastatin | Statin Therapy | Stroke | Study | Vitamin B3 | Zocor